PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results